Polymerised placenta haemoglobin attenuates cold ischaemia/reperfusion injury in isolated rat heart

Microvascular Research

Volumn 82, Issue 3, 2011, Pages 430-438

  Wei, Li ^a   Wu, Ruo Bin ^a   Yang, Cheng Min ^b   Zheng, Shao Yi ^a   Yu, Xi Yong ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b Institute of Tianjin Union Biotechnology Development   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HTK SOLUTION; I KAPPA B; INTERLEUKIN 1BETA; MESSENGER RNA; OXYGEN; POLYMERIZED HEMOGLOBIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; HEART ARREST; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PROTECTION; ISOLATED HEART; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; COLD ISCHEMIA; FEMALE; GLUCOSE; HEMOGLOBINS; INTERLEUKIN-1BETA; MANNITOL; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NECROSIS; NF-KAPPA B; ORGAN PRESERVATION SOLUTIONS; OXIDATIVE STRESS; OXYGEN; PERFUSION; PLACENTA; POTASSIUM CHLORIDE; PREGNANCY; PROCAINE; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; RNA, MESSENGER; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR FUNCTION, LEFT;

RATTUS;

EID: 81055156882     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2011.08.010     Document Type: Article

References (48)

1. Aprahamian C.J., Lorenz R.G., Harmon C.M., Dimmit R.A. Toll-like receptor 2 is protective of ischemia-reperfusion-mediated small-bowel injury in a murine model. Pediatr. Crit. Care Med. 2008, 9:105-109.
2. Arslan F., De Kleijn D.P.V., Timmers L., Doevendans P.A., Pasterkamp G. Bridging innate immunity and myocardial ischemia/reperfusion injury: the search for therapeutic targets. Curr. Pharm. Des. 2008, 14(12):1205-1216.
3. Baldwin W.M., Larsen C.P., Fairchild R.L. Innate immune responses to transplants: a significant variable with cadaver donors. Immunity 2006, 14(4):369-376.
4. Becker L.B. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc. Res. 2004, 61:461-470.
5. Bol G.F., Jurrmann N., Brigelius-Flohe R. Recruitment of the interleukin-1 receptor (IL-1RI)-associated kinase IRAK to the IL-1RI is redox regulated. Biol. Chem. 2003, 384:609-617.
6. Bolli R., Becker L., Gross G., Mentzer R., Balshaw D., Lathrop D.A. Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ. Res. 2004, 95:125-134.
7. Brown M.A., Jones W.K. NF-kB action in sepsis: the innate immune system and the heart. Front. Biosci. 2004, 9:1201.
8. Burmeister M.A., Rempf C., Standl T.G., Rehberg S., Bartsch-Zwemke S., Krause T., Tuszynski S., Gottschalk A., Schulte am Esch J. Effects of prophylactic or therapeutic application of bovine haemoglobin HBOC-200 on ischaemia-reperfusion injury following acute coronary ligature in rats. Br. J. Anaesth. 2005, 95:737-745.
9. Caswell J.E., Strange M.B., Rimmer D.M., Gibson M.F., Cole P., Lefer D.J. A novel hemoglobin-based blood substitute protects against myocardial reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:1796-1801.
10. Cavassani K.A., Ishii M., Wen H., Schaller M.A., Lincoln P.M., Lukacs N.W. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J. Exp. Med. 2008, 205:2609-2621.
11. Fan G., Ren X., Qian J., Yuan Q., Nicolaou P., Wang Y., Jones W.K., Chu G., Kranias E.G. Novel cardioprotective role of a small heat-shock protein, Hsp20, against ischemia/reperfusion injury. Circulation 2005, 111:1792-1799.
12. Fialkow L., Wang Y., Downey G.P. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic. Biol. Med. 2007, 42:153-164.
13. George I., Yi G.H., Schulman A.R., Morrow B.T., Cheng Y., Gu A., Zhang G., Oz M.C., Burkhoff D., Wang J.A. Polymerized bovine hemoglobin oxygen carrier preserves regional myocardial function and reduces infarct size after acute myocardial ischemia. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:1126-1137.
14. Gill R., Tsung A., Billiar T. Linking oxidative stress to inflammation: Toll-like receptors. Free Radic. Biol. Med. 2010, 48(9):1121-1132.
15. Gourdin M.J., Bree B., De Kock M. The impact of ischaemia-reperfusion on the blood vessel. Eur. J. Anaesthesiol. 2009, 26:537-547.
16. Halloran P.F., Autenried P., Ramassar V., Urmson J., Cockfield S. Local T cell responses induce widespread MHC expression: evidence that IFN-γ induces its own expression in remote sites. J. Immunol. 2005, 148(12):3837-3846.
17. Hansen P.R. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 2006, 91(6):1872-1885.
18. Ito I., Fukazawa J., Yoshida M. Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. J. Biol. Chem. 2007, 282:16336-16344.
19. Jordan J.E., Zhao Z.-Q., Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc. Res. 2007, 43(4):860-878.
20. Kazama H., Ricci J.E., Herndon J.M., Hoppe G., Green D.R., Ferguson T.A. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 2008, 29:21-32.
21. Kenneth N.S., Rocha S. Regulation of gene expression by hypoxia. Biochem. J. 2008, 414(1):19-29.
22. Khandoga A.G., Khandoga A., Anders H.J., Krombach F. Postischemic vascular permeability requires both TLR-2 and TLR-4, but only TLR-2 mediates the transendothelial migration of leukocytes. Shock 2009, 31:592-598.
23. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 2004, 4:181-189.
24. Li Q., Verma I.M. NF-kB regulation in the immune system. Nat. Rev. Immunol. 2004, 2:725.
25. Li T., Yu R., Zhang H.H., Wang H., Liang W.G., Yang X.M., Yang C.M. A method for purification and viral inactivation of human placenta hemoglobin. Artif. Cells Blood Substit. Immobil. Biotechnol. 2006, 34:175-188.
26. Li T., Li J., Liu J., Zhang P., Wu W., Zhou R., Li G., Zhang W., Yi M., Huang H. Polymerized placenta hemoglobin attenuates ischemia/reperfusion injury and restores the nitroso-redox balance in isolated rat heart. Free Radic. Biol. Med. 2009, 46:397-405.
27. Li T., Liu J., Yang Q., Wu W., Zhang P., Yang J., Li J., Zhang W., Yang C. Polymerized placenta hemoglobin improves cardiac functional recovery and reduces infarction size of isolated rat heart. Artif. Cells Blood Substit. Immobil. Biotechnol. 2009, 37:48-52.
28. Liew F.Y., Xu D., Brint E.K., O'Neill L.A.J. Negative regulation of Toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 2005, 5(6):446-458.
29. Magder S. Reactive oxygen species: toxic molecules or spark of life?. Crit. Care. 2006, 10:208.
30. Marino J.H., Cook P., Miller K.S. Accurate and statistically verified quantification of relative mRNA abundances using SYBR Green I and real-time RT-PCR. J. Immunol. Methods 2003, 283:291-306.
31. McNeil C.J., Smith L.D., Jenkins L.D., York M.G., Josephs M.J. Hypotensive resuscitation using a polymerized bovine hemoglobin-based oxygen-carrying solution (HBOC-201) leads to reversal of anaerobic metabolism. J. Traumatol. 2004, 50:1063-1075.
32. Moore E.E., Cheng A.M., Moore H.B., Masuno T., Johnson J.L. Hemoglobin-based oxygen carriers in trauma care: scientific rationale for the US multicenter prehospital trial. World J. Surg. 2006, 30:1247-1257.
33. O'Neill L.A.J. How Toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 2006, 18(1):3-9.
34. Ohashi K., Burkart V., Flohe S., Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J. Immunol. 2000, 164:558-561.
35. Olofsson C., Nygards E.B., Ponzer S., Fagrell B., Przybelski R., Keipert P.E., Winslow N., Winslow R.M. A randomized, single-blind, increasing dose safety trial of an oxygen-carrying plasma expander (Hemospan) administered to orthopaedic surgery patients with spinal anaesthesia. Transfus. Med. 2008, 18:28-39.
36. Palm N.W., Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol. Rev. 2009, 227(1):221-233.
37. Park H.S., Jung H.Y., Park E.Y., Kim J., Lee W.J., Bae Y.S. Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J. Immunol. 2004, 173:3589-3593.
38. Park J.S., Svetkauskaite D., He Q., Kim J.Y., Strassheim D., Ishizaka A. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 2004, 279:7370-7377.
39. Rocha S. Gene regulation under low oxygen: holding your breath for transcription. Trends Biochem. Sci. 2007, 32:389-397.
40. Serruys P., Vranckx P., Slagboom T., Regar E., Meliga E., de Winter R., Heyndrickx G., Schuler G., van Remortel E., Dubé G.P., Symons J. Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD. EuroIntervention 2008, 3:600-609.
41. Shibata R., Sato K., Pimentel D.R., Takemura Y., Kihara S., Ohashi K., Funahashi T., Ouchi N., Walsh K. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat. Med. 2005, 11:1096-1103.
42. Standl T., Freitag M., Burmeister M.A., Horn E.P., Wilhelm S., Am Esch J.S. Hemoglobin-based oxygen carrier HBOC-201 provides higher and faster increase in oxygen tension in skeletal muscle of anemic dogs than do stored red blood cells. J. Vasc. Surg. 2003, 37:859-865.
43. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3. RESEARCH0034.
44. Weiser M.R., Williams J.P., Moore F.D. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J. Exp. Med. 2006, 183(5):2343-2348.
45. Weisman H.F., Bartow T., Leppo M.K. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 2004, 249(4965):146-151.
46. Wu W., Yang Q., Li T., Zhang P., Zhou R., Yang C. Hemoglobin-based oxygen carriers combined with anticancer drugs may enhance sensitivity of radiotherapy and chemotherapy to solid tumors. Artif. Cells Blood Substi. Immobil. Biotechnol. 2009, 37:163-165.
47. Yu B., Shahid M., Egorina E.M., Sovershaev M.A. Endothelial dysfunction enhances vasoconstriction due to scavenging of nitric oxide by a hemoglobin-based oxygen carrier. Anesthesiology 2010, 112(3):586-594.
48. Zahringer U., Lindner B., Inamura S., Heine H., Alexander C. TLR2 -promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 2008, 213(3-4):205-224.